CLINICAL TRIALS PROFILE FOR DEXEDRINE
✉ Email this page to a colleague
All Clinical Trials for Dexedrine
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00296686 ↗ | Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression | Terminated | New York State Psychiatric Institute | Phase 4 | 2001-09-01 | This pilot study will assess the efficacy of several sequential pharmacological treatments for patients with Refractory Depression. |
NCT00363298 ↗ | Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD | Completed | Obsessive Compulsive Foundation | N/A | 2006-08-01 | The study hypothesis is that dextro-amphetamine (d-amphetamine) will be safe and effective when used to augment treatment for Obsessive-Compulsive Disorder (OCD), and that tolerance (loss of therapeutic effect) to the medication will not develop over a period of several weeks. |
NCT00363298 ↗ | Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD | Completed | Stanford University | N/A | 2006-08-01 | The study hypothesis is that dextro-amphetamine (d-amphetamine) will be safe and effective when used to augment treatment for Obsessive-Compulsive Disorder (OCD), and that tolerance (loss of therapeutic effect) to the medication will not develop over a period of several weeks. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Dexedrine
Condition Name
Clinical Trial Locations for Dexedrine
Trials by Country
Clinical Trial Progress for Dexedrine
Clinical Trial Phase
Clinical Trial Sponsors for Dexedrine
Sponsor Name